AIMS: To describe how changes in legislation to restrict paracetamol sales have affected overdose discharges and death associated with the drug in Scotland. METHODS: A descriptive analysis of routine death and hospital discharge data for the entire Scottish population between 1995 and 2004. Patients in Scotland participated who were discharged from hospital with a diagnosis of poisoning; deaths in Scotland from diagnosis of poisoning 1995-2003 were also analysed. Outcome measures were changes in mortality and overdose due to poisoning involving paracetamol. A comparison was made of in-hospital and out-of-hospital mortality in fatalities involving paracetamol. RESULTS: The majority of paracetamol-associated deaths were due to co-proxamol. Deaths associated with paracetamol alone or with ethanol occurred principally in hospital and were a minority of deaths overall. The proportion of in-hospital deaths attributed to paracetamol increased (post/pre ratio 1.347; 95% confidence interval 1.076, 1.639; P = 0.013). Overall numbers of cases discharged with poisoning fell. The proportion of these involving paracetamol in any form increased significantly in all groups except young men aged 10 to <20 years. CONCLUSIONS: Legislation has not reduced mortality or proportional use of paracetamol in overdose, both of which appear to have increased in Scotland since pack-size limitations. Other approaches are necessary to reduce the death rate from overdoses involving paracetamol.
AIMS: To describe how changes in legislation to restrict paracetamol sales have affected overdose discharges and death associated with the drug in Scotland. METHODS: A descriptive analysis of routine death and hospital discharge data for the entire Scottish population between 1995 and 2004. Patients in Scotland participated who were discharged from hospital with a diagnosis of poisoning; deaths in Scotland from diagnosis of poisoning 1995-2003 were also analysed. Outcome measures were changes in mortality and overdose due to poisoning involving paracetamol. A comparison was made of in-hospital and out-of-hospital mortality in fatalities involving paracetamol. RESULTS: The majority of paracetamol-associated deaths were due to co-proxamol. Deaths associated with paracetamol alone or with ethanol occurred principally in hospital and were a minority of deaths overall. The proportion of in-hospital deaths attributed to paracetamol increased (post/pre ratio 1.347; 95% confidence interval 1.076, 1.639; P = 0.013). Overall numbers of cases discharged with poisoning fell. The proportion of these involving paracetamol in any form increased significantly in all groups except young men aged 10 to <20 years. CONCLUSIONS: Legislation has not reduced mortality or proportional use of paracetamol in overdose, both of which appear to have increased in Scotland since pack-size limitations. Other approaches are necessary to reduce the death rate from overdoses involving paracetamol.
Authors: Christopher L Sheen; John F Dillon; D Nicholas Bateman; Kenneth J Simpson; Thomas M MacDonald Journal: Br J Clin Pharmacol Date: 2002-10 Impact factor: 4.335
Authors: Caroline Daly; Eve Griffin; Elaine McMahon; Paul Corcoran; Roger T Webb; Darren M Ashcroft; Ella Arensman Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2020-11-04 Impact factor: 4.328
Authors: Keith Hawton; Helen Bergen; Sue Simkin; Ella Arensman; Paul Corcoran; Jayne Cooper; Keith Waters; David Gunnell; Navneet Kapur Journal: BMC Public Health Date: 2011-06-10 Impact factor: 3.295
Authors: Mhairi Mackenzie; Avril Blamey; Emma Halliday; Margaret Maxwell; Allyson McCollam; David McDaid; Joanne MacLean; Amy Woodhouse; Stephen Platt Journal: BMC Public Health Date: 2007-07-06 Impact factor: 3.295
Authors: Adrian Martinez-De la Torre; Stefan Weiler; Dominic Stefan Bräm; Samuel S Allemann; Hugo Kupferschmidt; Andrea M Burden Journal: JAMA Netw Open Date: 2020-10-01